Dermatologicals in Azerbaijan

 Published On: Sep, 2016 |    No of Pages: 23 |  Published By: Euromonitor | Format: PDF
With the poor environmental situation in Azerbaijan and increasing construction works, dermatologicals has become a good solution for the quick, easy and convenient treatment of skin problems. In day-to-day life dermatologicals products are becoming more popular amongst consumers.

Dermatologicals in Azerbaijan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
DERMATOLOGICALS IN AZERBAIJAN

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2011-2016
Table 2 Sales of Dermatologicals by Category: % Value Growth 2011-2016
Table 3 NBO Company Shares of Dermatologicals: % Value 2012-2016
Table 4 LBN Brand Shares of Dermatologicals: % Value 2013-2016
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2013-2016
Table 6 Forecast Sales of Dermatologicals by Category: Value 2016-2021
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2016-2021
Actavis Group in Consumer Health (azerbaijan)
Strategic Direction
Key Facts
Summary 1 Actavis Group: Key Facts
Competitive Positioning
Summary 2 Actavis Group: Competitive Position 2016
Bayer AG in Consumer Health (azerbaijan)
Strategic Direction
Key Facts
Summary 3 Bayer AG: Key Facts
Competitive Positioning
Summary 4 Bayer AG: Competitive Position 2016
Executive Summary
Drug Pricing Regulation Negatively Impacts Pharmaceuticals
Demand Increases for Cheaper Drugs From Neighbour Countries in 2016
Actavis Group Leads the Industry in 2016
Parapharmacies Taking Over As the Leading Distribution Channel
Consumer Health Is Expected To See Limited Growth Over the Forecast Period
Key Trends and Developments
National Currency Devaluation Results in A Fall in Volume and A Rise in Value Sales
State Authorities Regulate Prices on Medicines From August 2015 To Avoid A Significant Price Jump
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Distribution of Consumer Health by Format: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format and Category: % Value 2016
Table 16 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 5 Research Sources
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.